新诺威(300765.SZ)发预亏，预计2025年度归母净亏损1.7亿元至2.55亿元，同比由盈转亏

智通财经01-15

智通财经APP讯，新诺威(300765.SZ)发布2025年度业绩预告，预计全年归属于上市公司股东净亏损1.7亿元至2.55亿元，同比由盈转亏。报告期内，公司为加速推进创新管线，持续加大研发投入。多款在研产品取得重要进展：2025年，公司4款抗体药物、6款ADC产品及1款mRNA疫苗首次取得临床试验批准;1款单抗产品(注射用奥马珠单抗)新适应症获批上市;1款单抗产品(帕妥珠单抗注射液)上市申请获得...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2603260843?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-15 17:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603260843","market":"fut","top_or_hot":-1,"title":"新诺威(300765.SZ)发预亏，预计2025年度归母净亏损1.7亿元至2.55亿元，同比由盈转亏","media":"智通财经","content":"<div>\n<p>智通财经APP讯，新诺威(300765.SZ)发布2025年度业绩预告，预计全年归属于上市公司股东净亏损1.7亿元至2.55亿元，同比由盈转亏。报告期内，公司为加速推进创新管线，持续加大研发投入。多款在研产品取得重要进展：2025年，公司4款抗体药物、6款ADC产品及1款mRNA疫苗首次取得临床试验批准;1款单抗产品(注射用奥马珠单抗)新适应症获批上市;1款单抗产品(帕妥珠单抗注射液)上市申请获得...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1393345.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新诺威(300765.SZ)发预亏，预计2025年度归母净亏损1.7亿元至2.55亿元，同比由盈转亏</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新诺威(300765.SZ)发预亏，预计2025年度归母净亏损1.7亿元至2.55亿元，同比由盈转亏\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-15 17:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1393345.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，新诺威(300765.SZ)发布2025年度业绩预告，预计全年归属于上市公司股东净亏损1.7亿元至2.55亿元，同比由盈转亏。报告期内，公司为加速推进创新管线，持续加大研发投入。多款在研产品取得重要进展：2025年，公司4款抗体药物、6款ADC产品及1款mRNA疫苗首次取得临床试验批准;1款单抗产品(注射用奥马珠单抗)新适应症获批上市;1款单抗产品(帕妥珠单抗注射液)上市申请获得...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1393345.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0226","symbol_name":"食品制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1393345.html","article_id":"2603260843","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603260843","pubTimestamp":1768468914,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，新诺威 发布2025年度业绩预告，预计全年归属于上市公司股东净亏损1.7亿元至2.55亿元，同比由盈转亏。报告期内，公司为加速推进创新管线，持续加大研发投入。报告期内，公司于2025年11月初完成对控股子公司巨石生物29%少数股权的收购，持股比例提升至80%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300765":"新诺威","BK0226":"食品制造"},"translate_title":"Xinnuowei (300765. SZ) issued a pre-loss, and it is estimated that the net loss attributable to the parent company in 2025 will be 170 million to 255 million yuan, turning from profit to loss year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300765":1.5},"content_text":"智通财经APP讯，新诺威(300765.SZ)发布2025年度业绩预告，预计全年归属于上市公司股东净亏损1.7亿元至2.55亿元，同比由盈转亏。报告期内，公司为加速推进创新管线，持续加大研发投入。多款在研产品取得重要进展：2025年，公司4款抗体药物、6款ADC产品及1款mRNA疫苗首次取得临床试验批准;1款单抗产品(注射用奥马珠单抗)新适应症获批上市;1款单抗产品(帕妥珠单抗注射液)上市申请获得受理;另有2款ADC产品进入III期临床阶段。受上述研发活动推动，全年研发费用增至约10亿元，同比有较大增长，是影响当期利润的重要因素。报告期内，公司于2025年11月初完成对控股子公司巨石生物29%少数股权的收购，持股比例提升至80%。目前巨石生物因在研管线投入较大尚未盈利，随着持股比例提高，其损益对公司合并财务报表归属于上市公司股东的净利润的影响相应扩大。报告期内，公司积极巩固功能性原料业务优势地位，提升咖啡因类产品销量，但受市场因素影响，公司咖啡因类产品毛利率及盈利水平较去年同期略有下降，进而导致功能性原料业务的利润有所下降。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603260843","isCrawlerRequest":true}